Shanghai Securities News China Securities Network News (reporter Luo Min) Enhua Pharmaceutical announced that the company recently received the State Drug Administration approved and issued a "Notice of Approval of Drug Supplement application" on "Sulpiride Tablets", approving that the drug passed the consistency evaluation of the quality and efficacy of generic drugs. Indications for supilide tablets: used for schizophrenia; have a certain effect on depressive symptoms; other uses are anti-vomiting.
![Announcement #Enhua Pharmaceutical a new drug of anesthesia class 1 was approved for clinical trials[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)